Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Models of Infectious Disease Agent Study (MIDAS) (RFA) Research Initiative CDC NIGMS, FIC Models of Infectious Disease Agent Study (MIDAS) is a collaboration of research and informatics groups to develop computational models of the interactions between infectious agents and their hosts, disease spread, prediction systems and response strategies. The models will be useful to policymakers, public health workers and other researchers who want to better understand and respond to emerging infectious diseases. If a disease outbreak occurs, the MIDAS network may be called upon to develop specific models to aid public officials in their decision-making processes.
mPOWER mHealth Group Research Initiative CDC, CMS, FDA, HRSA, IHS NINR, CIT, FIC, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR Mobilizing Research supports the development, promotion, and dissemination of a wireless health research recruitment and data platform. In addition to being a primary data collection mechanism, the platform would be a data repository for both basic and applied health science, making validation and standardization of mobile health tools accessible.
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group Committee, Work group, Advisory group, or Task Force ACL, CMS, FDA NIBIB, NCI, NHLBI, NIA, NIAMS, NICHD, NIDCD, NIDCR, NINDS The Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group (IWG), originally organized under the auspices of the Subcommittee on Biotechnology of the National Science and Technology Council (NSTC), was established in 2000 to provide a forum for federal agencies involved in tissue science and engineering to stay informed of each other’s activities and coordinate research efforts. Its five-year plan was renewed in 2002 and new Terms of Reference were introduced in 2007. The MATES group now works independently of NSTC and is comprised of many participating agencies. The principal purpose of the MATES IWG is to provide a platform across which member agencies can interact and exchange information on tissue engineering efficiently and effectively. It is the means by which Federal agencies involved in tissue engineering stay informed of each other’s activities and coordinate their efforts in a timely and efficient manner. The MATES IWG organized and co-chaired the opening symposium of the 2014 meeting of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), held December 13-16, 2014. MATES members responded to a GAO review of regenerative medicine in FY15 and MATES is mentioned in the report that was released in June 2015.
Multinational Influenza Seasonal Mortality Study (MISMS) Research Research Initiative OS FIC, NHLBI, NIAID, NLM The Multinational Influenza Seasonal Mortality Study (MISMS) was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza and other rapidly transmissible respiratory viruses, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 35 countries (representing ~3.2 billion people), resulting in over 130 publications.
Muscular Dystrophy Coordinating Committee (MDCC) Committee, Work group, Advisory group, or Task Force ACL, CDC, FDA, HRSA NINDS, NHLBI, NIAMS, NICHD This Committee coordinates activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy.
My Family Health Portrait Resource Development CDC, HRSA, OSG NHGRI, NCI, NICHD My Family Health Portrait is the Web-based tool from NHGRI and the U.S. Surgeon General''s Family History Initiative that helps individuals track their family health history. Using any computer, an Internet connection and an up-to-date Web browser, individuals can provide health information to build a drawing of their family tree and a chart of their family health history. Both the chart and the drawing can be printed and shared with family members and an individual''s doctor.
Naloxone Workgroup Committee, Work group, Advisory group, or Task Force CDC, FDA NIDA The goal of this Workgroup is to discuss ways to implement the use of naloxone as emergency treatment for opioid overdose.
Nanomaterial Registry Resource Development CDC, FDA NCI, NIBIB, NIEHS The Nanomaterial Registry is an authoritative, fully curated resource available to the public that archives research data on nanomaterials and their biological and environmental implications.
Nanotechnology Characterization Laboratory Research Initiative FDA NCI, NIEHS The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications.
National Action Alliance for Suicide Prevention (NAASP) Committee, Work group, Advisory group, or Task Force ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP The National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership for advancing the National Strategy for Suicide Prevention. The mission of the NAASP is to champion suicide prevention as a national priority, to catalyze efforts to implement high priority objectives of the NAASP, and to cultivate the resources needed to sustain progress. The former NIMH Director was an ex officio member of the NAASP Executive Committee and served as Co-Chair of the NAASP Research Task Force. Additional NIMH staff members serve on task forces pertaining to LGBT Youth, Military and Veterans, Youth in Justice Settings, and American Indian/Alaska Natives. In 2014, NIMH staff contributed to and served as guest editors, authors, and co-authors of a journal supplement about suicide. In 2014, the National Action Alliance for Suicide Prevention’s Research Prioritization Task Force (RPTF) released the Nation’s first suicide research agenda: A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The Research Agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20% in five years and by 40% or greater in ten years, if multiple actions, informed by research, were fully implemented. In 2015, the RPTF released the first portfolio analyses of suicide research funding in the U.S. by federal and private funders.